Our long term objectives are to clarify the relationships between clearance functions, cell constituents and structure of the liver. Our approach is to perturb the system with a model toxin, identify the early impairments in function and then determine if alterations in selected cell constituents underlie the early functional impairments. Development of canalicular injury in fasted rats after administration of 1,1-dichloroethylene (1,1-DCE) provides a useful in vivo model system to study the relationships between morphological changes in this liver compartment and impairments in hepatobiliary clearance because a) 1,1-DCE produces striking early alterations in bile canaliculi and b) fed rats are much less vulnerable to the hepatoxicity of 1,1-DCE than fasted rats. This fed-fasted difference allows changes in clearance functions which are injury-associated to be distinguished from changes which may be due to the metabolism of this xenobiotic. The proposed studies will be conducted in unanesthetized, unrestrained rats with previously implanted bile duct, jugular vein and portal vein cannulas.
Specific aims are: 1) Use marker solutes, endogenous when possible, to identify hepatobiliary clearance impairments which are associated with early canalicular injury. 2) Differentiate between impairments in uptake vs transport processes by pharmacokinetics and between focal vs centrolobular permeability changes by ultrastructure. 3) Determine if canalicular regurgitation or biliary leakiness could underlie the impaired solute clearance. 4) Determine if alterations in specific liver constituents, i.e., membrane ATPases (by histochemistry), nucleotides (by HPLC) or cytoskeletal constituents (by immunocytochemical staining), could underlie clearance impairments. These in vivo, time-course studies should clarify relationships between the development of canalicular injury and the functional integrity of major processes of bile formation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
1R01AM034806-01A1
Application #
3153415
Study Section
Pathology B Study Section (PTHB)
Project Start
1985-09-01
Project End
1988-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Kanz, M F; Kaphalia, L; Mohsin, S et al. (1994) Hyperthyroidism increases covalent binding and biliary excretion of 1,1-dichloroethylene in rats. J Toxicol Environ Health 41:187-206
Moslen, M T; Dunsford, H A; Karnasuta, C et al. (1989) Histochemical and immunocytochemical evidence of early, selective bile canaliculi injury after 1,1-dichloroethylene in rats. Am J Pathol 134:1099-112
Moslen, M T; Kanz, M F; Bhatia, J et al. (1988) Two cannula method for parenteral infusion and serial blood sampling in the freely moving rat. JPEN J Parenter Enteral Nutr 12:633-7
Moslen, M T; Kanz, M F; Ferguson, A E (1988) A stable colorimetric assay to measure toxin elevation of inorganic phosphate in bile. Anal Biochem 168:405-10
Kanz, M F; Whitehead, R F; Ferguson, A E et al. (1988) Potentiation of 1,1-dichloroethylene hepatotoxicity: comparative effects of hyperthyroidism and fasting. Toxicol Appl Pharmacol 95:93-103